Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05502107 · ClinicalTrials.gov registry record · NA
Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 984
- Enrollment target
NCT05502107: Completed NA study, sponsored by Emory University.
NCT05502107 is a NA study that has completed, run by Emory University. The registered enrollment target is 984 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05502107, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 984 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the impact of an Emergency Medical Services (EMS) based sepsis screening and early warning protocol on the timing of early sepsis care in the Emergency Department (ED).
Primary Outcome
Among eligible EMS patients with sepsis, the time from ED arrival to first antibiotic administration (parenteral only) in the ED will be examined. Time will be censored at the time of hospital admission or ED discharge.
Interventions
- BEHAVIORAL PRESS Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 984 participants |
| Start Date | 2023-06-27 |
| Est. Completion | 2025-07-15 |
| Phase | NA |
What the finished NCT05502107 record still lists
NCT05502107 is an interventional study that assigns participants to a tested intervention. The registered 984 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 1 intervention - of which PRESS Intervention is the first listed.
NCT05502107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05502107 about?
NCT05502107 is a clinical study titled "Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events". The primary purpose of this study is to evaluate the impact of an Emergency Medical Services (EMS) based sepsis screening and early warning protocol on the timing of early sepsis care in the Emergency Department (ED).
What is the current status of trial NCT05502107?
This trial is currently completed. It is a NA study. The enrollment target is 984 participants. The study started on 2023-06-27. Estimated completion is 2025-07-15.
What interventions are being tested in trial NCT05502107?
The interventions under investigation include: PRESS Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05502107?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05502107's enrollment target sits among peer trials
984 122nd of 2000 higher than 1,879 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06989437 · 982 participants · Phase 2
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- NCT06959095 · 981 participants · Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT06337097 · 980 participants · NA
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI